-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Oncotelic Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2019 to Q2 2025.
- Oncotelic Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2025 was 453M shares, a 12.8% increase year-over-year.
- Oncotelic Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 396M shares, a 13.4% decline from 2022.
- Oncotelic Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 457M shares, a 50.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)